Inovio PharmaceuticalsINO
那斯達克 · USD
1.15
-0.01
(-0.86%)
收盤 09/17 03:59 (UTC+8)
盤後
1.13
1.13
(-1.74%)
09/17 03:59 (UTC+8)
Inovio PharmaceuticalsINO
1.15
-0.01
(-0.86%)
財務數據
損益表
- -
- 0.00
- -
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -44.44
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | 65 | 117 | - | 101 | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | 65 | 117 | - | 101 | - |
營業費用 | 18,625 | 21,950 | 17,476 | 21,210 | 23,084 | 25,116 | 20,486 | 27,348 | - | 31,485 |
研發費用 | 10,827 | 14,070 | 10,261 | 13,333 | 14,521 | 16,091 | 12,885 | 18,734 | 23,088 | 20,914 |
推銷及管理費用 | 7,798 | 7,880 | 7,215 | 7,877 | 8,563 | 9,025 | 7,601 | 8,614 | 10,210 | 10,571 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -18,625 | -21,950 | -17,477 | -21,210 | -23,085 | -25,051 | -20,370 | -27,347 | -33,197 | -31,485 |
其他收入及費用 | 12,518 | 4,292 | 21,624 | -23,902 | -1,971 | 4,520 | 1,752 | 527 | 1,315 | 818 |
利息費用 | - | - | - | - | - | - | - | - | - | 178 |
稅前純益 | -6,107 | -17,658 | 4,147 | -45,112 | -25,055 | -20,530 | -18,618 | -26,821 | -31,882 | -30,845 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | - | -19,683 | 3,765 | -45,497 | -23,519 | -19,695 | -19,382 | -25,165 | -32,237 | -30,470 |
基本每股稅後盈餘(元) | -0.07 | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 | -0.56 | -0.89 | -1.19 | -1.31 |
稀釋每股稅後盈餘(元) | -0.06 | -0.28 | 0.31 | -1.00 | -0.61 | -0.51 | -0.60 | -0.87 | -1.17 | -1.31 |
基本平均股數(千股) | 81619.00 | 69101.00 | 57934.00 | 52168.00 | 38830.00 | 38613.00 | 30015.00 | 28140.00 | 27197.00 | 23291.00 |
稀釋平均股數(千股) | 81619.00 | 69101.00 | 57934.00 | 52168.00 | 38830.00 | 38613.00 | 30015.00 | 28140.00 | 27197.00 | 23291.00 |
還原基本每股稅後盈餘(元) | -0.07 | -0.28 | 0.18 | -0.87 | -0.61 | -0.51 | -0.56 | -0.89 | -1.19 | -1.31 |
還原稀釋每股稅後盈餘(元) | -0.06 | -0.28 | 0.31 | -1.00 | -0.61 | -0.51 | -0.60 | -0.87 | -1.17 | -1.31 |
還原基本平均股數(千股) | 81,619 | 69,101 | 57,934 | 52,168 | 38,830 | 38,613 | 30,015 | 28,140 | 27,197 | 23,291 |
還原稀釋平均股數(千股) | 81,619 | 69,101 | 57,934 | 52,168 | 38,830 | 38,613 | 30,015 | 28,140 | 27,197 | 23,291 |
EBITDA(千元) | 758 | -18,948 | 4,466 | -44,683 | -22,790 | -18,952 | -18,786 | -24,755 | -31,879 | -30,217 |